Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The new visual scale is a quick and effective way to measure hair loss in women.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Many research paper titles in dermatology journals lack scientific precision.

5% minoxidil significantly increases hair follicle density.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

The hairline can reliably guide neurosurgical planning.

Dermatophytosis is common in young, male Shirazi Persian cats, affecting ears, face, and abdomen.

Granuloma faciale can occur on the scalp, especially in people with advanced hair loss, and may improve with treatment.

Erbium-YAG laser treatment improved folliculitis decalvans without causing hair loss.

Dermatology residency programs need better DEI training to improve care for diverse patients.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

The document concludes that proper diagnosis and treatment of hair shaft disorders require understanding their unique causes and avoiding hair-damaging practices.